Argentina approves Sinopharm vaccine for children aged 3 to 11 years


the government of Argentina announced this Friday (1) the approval of the use of Sinopharm vaccine, of Chinese origin, to immunize children aged 3 to 11 against the covid-19, the only age group that has not yet started the immunization process in the South American country.

“It’s a big step in our vaccination campaign and it adds to the escalation of teen vaccinations that we’re planning for October,” Health Minister Carla Vizzotti said at a joint press conference with her Education colleague, Jaime Perczyk.

About 5.5 to 6 million children between 3 and 11 years old are able to be vaccinated, for which Argentina already has a stock of almost 10 million doses of Sinopharm and foresees the arrival of 2.75 million for the next week.

Sinopharm’s immunizer is given in two doses, 28 days apart.

“Argentina will close the year 2021 with all its population over the age of 3 covered” against the coronavirus, promised the minister.

Vizzotti explained that for this approval they relied on the results of phase 1 and 2 clinical trials carried out in children in China and the United Arab Emirates, as well as the experience in Chile, where another vaccine “with an equal platform” is applied in this age group.